BioCentury
ARTICLE | Clinical News

APC-100: Phase I/IIa started

September 5, 2011 7:00 AM UTC

Adamis began a U.S. Phase I/IIa trial to evaluate oral APC-100. Adamis has exclusive rights to APC-100 from Colby under a 2010 deal (see BioCentury, March 8, 2010). ...